Search results for "From ACP Internist"


 
Results 11 - 20 of about 80 for "From ACP Internist".

September 16, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Teaching diabetes self-management ‘basic survival skills' | ACP Diabetes Monthly

Diabetes self-management education is a cost-efficient, effective treatment that is underused in the United States, according to speakers at the 2012 annual meeting of the American Diabetes Association.

Diabetes Collaborative Registry seeks primary care participants | ACP Diabetes Monthly

ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality of a practice's

Newer, older insulin formulations may offer similar glucose-lowering effects | ACP Diabetes Monthly

The findings may help inform decisions about insulin therapy for patients with type 2 diabetes, for example, when minimizing weight gain or nocturnal hypoglycemia is a priority.

New guideline offers recommendations for older patients with diabetes or prediabetes | ACP Diabetes Monthly

The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.

Task Force recommends screening for type 2 diabetes in overweight, obese adults | ACP Diabetes Monthly

The U.S. Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in overweight and obese adults ages 40 to 70 years.

Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds | ACP Diabetes Monthly

More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.

Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD | ACP Diabetes Monthly

The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.

ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Analysis finds several treatments for painful diabetic neuropathy more effective than placebo | ACP Diabetes Monthly

A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.

Result Page: Prev   1   2   3   4   5   6   7   8   Next